C

Football. Fitness. LE. $XRP

[C @codyvyv]

@rorynotsorry “I know what I’m doing” but talking about putting test in the fridge 🤣

[Midjourney @midjourney]

Announcing a new division of Midjourney called "Midjourney Medical"

[Dallas Cowboys @dallascowboys]

A total Tyler takeover 🕵️‍♂️

🎟️ Get @SeatGeek tickets now ➡️ https://t.co/eoYkEktfUh

📺 NFL Schedule Release tonight at 7pm CT on @nflnetwork

[Bobby Belt @BobbyBeltTX]

"One guy isn't going to fix the Cowboys defense."

Yes...but Caleb Downs might get close.

[C @codyvyv]

@FootsDaKing It almost looks like he’s still working on trusting the knee and being 100% fluid but that could just be me looking too hard with knowledge of the injury

[Andrew D. Huberman, Ph.D. @hubermanlab]

Retatrutide is a real challenge to those that liked to bash on other GLP1 agonists etc because it’s used by (soon) everyone. FTR: I’ve not tried GLP1 agonists. If I ever do I will say as I’ve always shared what I take & try & halt taking & amounts since 2021 when we launched HLP.

[Andrew D. Huberman, Ph.D. @hubermanlab]

All the celebs now getting that retrutatide look. If you want to know what will be massive on legal RX market 2 years ahead in the fat loss, muscle, vitality space… it always goes from bodybuilding (GH, TRT, GLPs, Retra.) to Hollywood to mainstream. EVERY TIME. Since the 80s.

[Wholesome Side of 𝕏 @itsme_urstruly]

When you realise that going slow is the secret to a regulated nervous system.

[FergSZN @FergSZN]

Dak Prescott throwing over the middle

[C @codyvyv]

@SaraGonzalesTX @rascal113646 Then you’re retarded

[C @codyvyv]

@superslim9494 @jane__remover 🤣

[Bryan Johnson @bryan_johnson]

I’d cancel your AG1 subscription. They just completed a clinical trial and the results show no clinical benefit. 

This has been obvious for years.  AG1 has no real product substance and is fundamentally an influencer heist.  

Two simple alternatives (75% and 56% less $), outperform AG1 in randomized clinical trials.

Two simple mono-ingredient alternatives that outperform AG1:

1. Chicory inulin 12 g daily ($20/mo)
2. Resistant starch 30 g daily for 12 weeks ($35/mo)

AG1 is not worth $79/mo.

AG1 study results (4-weeks, N=30):
+ No significant changes in blood biomarkers compared to placebo (CBC, CMP, lipids).
+ No statistically significant improvement in digestive quality-of-life scores (p = 0.058).
+ No significant metabolic or inflammatory biomarker benefits of any kind within the scope of what was measured in the trial.
+ Only small shifts in microbiome taxa but clinically irrelevant at this stage.
+ The intervention did not increase microbiome diversity compared to placebo. Alpha diversity was unchanged, and the taxa changes seen were only from pre- to post-analysis within each group. Between-group differences were limited, and the placebo actually showed similar or even potentially larger shifts. This means the observed changes fall within normal placebo-driven variability, not a real treatment effect. No global microbiota shifts were detected.

Chicory inulin 12 g in constipation patients
+ 12 g of chicory inulin daily for 4 weeks (compared to maltodextrin placebo)
+ Global microbiota shifts: enrichment in butyrate-producing Bifidobacterium and Anaerostipes, and depletion of the pro-inflammatory Bilophila.
+The effect was seen by comparing intervention vs placebo in a cross-over setting, a very rigorous type of clinical analysis in which each person serves as their own control, eliminating a lot of individual random noise.
+ The trial also met its primary objective by improving constipation symptoms in the targeted patient group.

Resistant starch daily 30g for 12 weeks in older adults
+ Significant increase in Bifidobacterium in both middle-aged and elderly participants, with an increase in the beneficial microbiome byproduct butyrate, and reductions in Proteobacteria (including inflammatory Escherichia–Shigella) in the elderly.
+ Resistant starch also significantly reduced blood glucose, and produced greater reductions in blood insulin and insulin resistance (HOMA-IR) in the elderly group.

[Bleacher Report @BleacherReport]

WHAT DID WE JUST WATCH!!?! CALEB WILLIAMS IS SOMETHING ELSE 😱

(via @NFL)

[C @codyvyv]

@VicLombardi No

[Barstool Sports @barstoolsports]

Making sure my gate exists before going to get food at the airport

[C @codyvyv]

@DAK_4_MVP Lmao

[C @codyvyv]

@stevewilldoit LFG

3Mnak3UzzCJiVVToxF2SrGCVxSYhhBCMqQ

[Jordan Schultz @Schultz_Report]

This effort by #Cowboys rookie Alijah Clark really caught my attention.

Incredible. And it's one every team should show their players.

[NFL @NFL]

Announcer Eric Collins was ELECTRIC on the call for @MiamiDolphins vs. @Panthers 🗣️